| Alison Hobson Shepherd, APRN | |
|
904 Holiday Dr Ste 404, Forrest City, AR 72335-9157 | |
| (870) 633-0215 | |
| Not Available |
| Full Name | Alison Hobson Shepherd |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 904 Holiday Dr Ste 404, Forrest City, Arkansas |
| Accepts Medicare Assignments | May be. She may accept the Medicare-approved amount; you may be billed for more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619460813 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | ATP001299 (Arkansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Changes Behavioral Health, Llc | 6103149653 | 7 |
| Forrest City Emergency Physicians Pllc | 0648319624 | 13 |
News Archive
Meningitis B is particularly dangerous for children, leading to 120 deaths in the UK every year. There are around 1,200 new cases of meningitis B every year. Around 1 in 10 victims die and another 15 per cent are left with permanent disabilities - often limbs have to be amputated due to blood poisoning. The infection causes inflammation of the membranes surrounding the spinal cord and brain. Symptoms include a severe headache, vomiting, a rash, sensitivity to light and a stiff neck.
Researchers at the Institute for Stem Cell Biology and Medicine at UCLA were able to take normal tissue cells and reprogram them into cells with the same unlimited properties as embryonic stem cells, the cells that are able to give rise to every cell type found in the body.
In laboratory tests on multiple myeloma cells, University of Rochester researchers found that this type of cancer expresses a protein that makes it an easy target for an existing class of diabetes drugs. After more investigation, they hope the discovery will lead to a new, targeted therapy for myeloma patients.
ADVENTRX Pharmaceuticals, Inc. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its product candidate ANX-530 (vinorelbine injectable emulsion).
› Verified 8 days ago
| Entity Name | Forrest City Clinic Company Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821293051 PECOS PAC ID: 1557457447 Enrollment ID: O20071024000213 |
News Archive
Meningitis B is particularly dangerous for children, leading to 120 deaths in the UK every year. There are around 1,200 new cases of meningitis B every year. Around 1 in 10 victims die and another 15 per cent are left with permanent disabilities - often limbs have to be amputated due to blood poisoning. The infection causes inflammation of the membranes surrounding the spinal cord and brain. Symptoms include a severe headache, vomiting, a rash, sensitivity to light and a stiff neck.
Researchers at the Institute for Stem Cell Biology and Medicine at UCLA were able to take normal tissue cells and reprogram them into cells with the same unlimited properties as embryonic stem cells, the cells that are able to give rise to every cell type found in the body.
In laboratory tests on multiple myeloma cells, University of Rochester researchers found that this type of cancer expresses a protein that makes it an easy target for an existing class of diabetes drugs. After more investigation, they hope the discovery will lead to a new, targeted therapy for myeloma patients.
ADVENTRX Pharmaceuticals, Inc. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its product candidate ANX-530 (vinorelbine injectable emulsion).
› Verified 8 days ago
| Entity Name | Forrest City Emergency Physicians Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497080501 PECOS PAC ID: 0648319624 Enrollment ID: O20091204000091 |
News Archive
Meningitis B is particularly dangerous for children, leading to 120 deaths in the UK every year. There are around 1,200 new cases of meningitis B every year. Around 1 in 10 victims die and another 15 per cent are left with permanent disabilities - often limbs have to be amputated due to blood poisoning. The infection causes inflammation of the membranes surrounding the spinal cord and brain. Symptoms include a severe headache, vomiting, a rash, sensitivity to light and a stiff neck.
Researchers at the Institute for Stem Cell Biology and Medicine at UCLA were able to take normal tissue cells and reprogram them into cells with the same unlimited properties as embryonic stem cells, the cells that are able to give rise to every cell type found in the body.
In laboratory tests on multiple myeloma cells, University of Rochester researchers found that this type of cancer expresses a protein that makes it an easy target for an existing class of diabetes drugs. After more investigation, they hope the discovery will lead to a new, targeted therapy for myeloma patients.
ADVENTRX Pharmaceuticals, Inc. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its product candidate ANX-530 (vinorelbine injectable emulsion).
› Verified 8 days ago
| Entity Name | Changes Behavioral Health, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114260486 PECOS PAC ID: 6103149653 Enrollment ID: O20150108001118 |
News Archive
Meningitis B is particularly dangerous for children, leading to 120 deaths in the UK every year. There are around 1,200 new cases of meningitis B every year. Around 1 in 10 victims die and another 15 per cent are left with permanent disabilities - often limbs have to be amputated due to blood poisoning. The infection causes inflammation of the membranes surrounding the spinal cord and brain. Symptoms include a severe headache, vomiting, a rash, sensitivity to light and a stiff neck.
Researchers at the Institute for Stem Cell Biology and Medicine at UCLA were able to take normal tissue cells and reprogram them into cells with the same unlimited properties as embryonic stem cells, the cells that are able to give rise to every cell type found in the body.
In laboratory tests on multiple myeloma cells, University of Rochester researchers found that this type of cancer expresses a protein that makes it an easy target for an existing class of diabetes drugs. After more investigation, they hope the discovery will lead to a new, targeted therapy for myeloma patients.
ADVENTRX Pharmaceuticals, Inc. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its product candidate ANX-530 (vinorelbine injectable emulsion).
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alison Hobson Shepherd, APRN 49 County Road 7429, Wynne, AR 72396-5005 Ph: (870) 270-0544 | Alison Hobson Shepherd, APRN 904 Holiday Dr Ste 404, Forrest City, AR 72335-9157 Ph: (870) 633-0215 |
News Archive
Meningitis B is particularly dangerous for children, leading to 120 deaths in the UK every year. There are around 1,200 new cases of meningitis B every year. Around 1 in 10 victims die and another 15 per cent are left with permanent disabilities - often limbs have to be amputated due to blood poisoning. The infection causes inflammation of the membranes surrounding the spinal cord and brain. Symptoms include a severe headache, vomiting, a rash, sensitivity to light and a stiff neck.
Researchers at the Institute for Stem Cell Biology and Medicine at UCLA were able to take normal tissue cells and reprogram them into cells with the same unlimited properties as embryonic stem cells, the cells that are able to give rise to every cell type found in the body.
In laboratory tests on multiple myeloma cells, University of Rochester researchers found that this type of cancer expresses a protein that makes it an easy target for an existing class of diabetes drugs. After more investigation, they hope the discovery will lead to a new, targeted therapy for myeloma patients.
ADVENTRX Pharmaceuticals, Inc. announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for its product candidate ANX-530 (vinorelbine injectable emulsion).
› Verified 8 days ago
Mrs. Susan Patton, A.P.N.,DNSC. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 901 Holiday Dr, Forrest City, AR 72335 Phone: 870-633-0880 Fax: 870-633-3801 | |
Lynzi Elizabeth Wiggins, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 5082 N Washington St, Forrest City, AR 72335 Phone: 870-261-9149 | |
Jessica Katherine Jones, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 114 N Washington St, Forrest City, AR 72335 Phone: 870-945-5465 | |
Elizabeth Anne Barnes, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6014 Highway 284, Forrest City, AR 72335 Phone: 870-208-3189 | |
Courtney Marie Morgan-dildine, APN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 904 Holiday Dr, Suite 406, Forrest City, AR 72335 Phone: 870-494-4000 Fax: 870-494-4033 | |
Deanna Michaelis, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 114 N Washington St, Forrest City, AR 72335 Phone: 870-970-3340 Fax: 870-383-3334 | |
Mrs. Gail Hayes Darby, CNP- FNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2530 West Broadway Ave, Forrest City, AR 72335 Phone: 870-581-4318 Fax: 870-270-5135 |